ストックスクリーナーアプリを入手
5.14
2.39%
0.12
アフターアワーズ：
5.15
0.01
+0.19%
前日終値:
$5.02
開ける：
$4.97
24時間の取引高:
54,851
Relative Volume:
0.45
時価総額：
$194.42M
収益：
$2.76M
当期純損益:
$-49.12M
株価収益率:
-4.3581
EPS:
-1.1794
ネットキャッシュフロー:
$-46.21M
1週間 パフォーマンス:
+6.86%
1か月 パフォーマンス:
-23.28%
6か月 パフォーマンス:
-2.47%
1年 パフォーマンス:
-41.06%
1日の値動き範囲:
$4.91
$5.45
1週間の範囲:
$4.50
$5.45
52週間の値動き範囲:
$4.22
$11.69
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
名前
Orchestra Biomed Holdings Inc
セクター
電話
646-343-9298
住所
150 UNION SQUARE DRIVE, NEW HOPE
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-02-24 | 開始されました | Piper Sandler | Overweight |
| 2023-02-07 | 開始されました | Chardan Capital Markets | Buy |
Orchestra Biomed Holdings Inc (OBIO) 最新ニュース
Rhumbline Advisers Buys 17,405 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider David P. Hochman Purchases 2,500 Shares - MarketBeat
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider David P. Hochman Purchases 2,500 Shares - Defense World
Orchestra BioMed executive acquires shares worth over $47k By Investing.com - Investing.com Australia
Orchestra BioMed executive acquires shares worth over $47k - Investing.com India
Orchestra BioMed executive acquires shares worth over $47k - Investing.com
Orchestra BioMed executive acquires shares worth over $47k By Investing.com - Investing.com UK
Market Update: Ocular Therapeutix Inc (OCUL) Sees Negative Movement, Closing at 8.46 - The Dwinnex
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Bought by Bank of New York Mellon Corp - Defense World
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Shares Sold by Logos Global Management LP - MarketBeat
Elevai Labs shares tumble on pricing of new stock offering - Sacramento Business Journal
Why Elevai Labs (ELAB) Stock Is Down 60% Today - Benzinga
Elevai Labs announces pricing of $8 million public offering - MSN
Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering - GlobeNewswire
Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering - StockTitan
L’Oreal partners with Evonik and Abolis to scale development of next-gen ingredients - GlobalCosmeticsNews
Video: A WONDERFUL WORLD Parades to Studio 54 - BroadwayWorld
The Cure 'Songs of a Lost World' billboard appears in NYC - Brooklyn Vegan
Exicure Shares More Than Double After Nasdaq Listing Extension - MarketWatch
Oxford Biomedica Emerges as OXB with Global Vision - TipRanks
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of European Wax Center, Inc.EWCZ - PR Newswire
Ocular Therapeutix Inc’s Market Journey: Closing Weak at 8.93, Down -0.78 - The Dwinnex
(OBIO) On The My Stocks Page - Stock Traders Daily
IPO NewsUP IPO Weekly Recap: 3 Biotechs Lead Active September IPO Market - Renaissance Capital
L'Oreal, Evonik join $38.6 million funding round for biotech start-up Abolis - Fashion Network
Interactive Bible Study Course Demonstrated to Over 200 Individuals at International Fair in Angola - JW News
L'Oreal, Evonik join $38.6 million funding round for biotech start-up Abolis - Marketscreener.com
Orchestra BioMed executive sells over $73k in company stock - Investing.com India
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Director Eric S. Fain Sells 2,000 Shares of Stock - MarketBeat
Orchestra BioMed director sells over $30k in company shares - Investing.com
Orchestra BioMed executive sells over $73k in company stock - Investing.com
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Sells $41,705.70 in Stock - Defense World
Have Orchestra BioMed Holdings Insiders Been Selling Stock? - Simply Wall St
Orchestra BioMed executive sells over $120k in company stock - Investing.com India
Insider Selling: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Sells 6,819 Shares of Stock - MarketBeat
Orchestra BioMed executive sells over $120k in company stock - Investing.com
Orchestra BioMed executive sells over $120k in company stock By Investing.com - Investing.com UK
Orchestra BioMed Initiates BackBeat Pivotal Study Of AVIM Therapy - MPO-mag
Orchestra BioMed (NASDAQ:OBIO) Receives New Coverage from Analysts at HC Wainwright - MarketBeat
Orchestra BioMed shares initiated with Buy by H.C. Wainwright - Investing.com
Orchestra BioMed shares initiated with Buy by H.C. Wainwright - Investing.com Australia
HC Wainwright Begins Coverage on Orchestra BioMed (NASDAQ:OBIO) - Defense World
Orchestra BioMed shares initiated with Buy by H.C. Wainwright - Investing.com India
Orchestra BioMed Holdings Reports Second Quarter 2024 Financial Results and Business Updates - MSN
David P. Hochman Acquires 2,500 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Stock - Defense World
Chardan Capital Comments on Orchestra BioMed Holdings, Inc.’s FY2024 Earnings (NASDAQ:OBIO) - Defense World
Research Analysts Set Expectations for Orchestra BioMed Holdings, Inc.'s FY2024 Earnings (NASDAQ:OBIO) - MarketBeat
Insider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Buys 2,500 Shares of Stock - MarketBeat
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Forecasted to Earn Q3 2024 Earnings of ($0.43) Per Share - Defense World
Q3 2024 Earnings Estimate for Orchestra BioMed Holdings, Inc. Issued By B. Riley (NASDAQ:OBIO) - MarketBeat
Orchestra BioMed (NASDAQ:OBIO) Announces Earnings Results, Misses Estimates By $0.04 EPS - MarketBeat
Orchestra Biomed Holdings Inc (OBIO) 財務データ
収益
当期純利益
現金流量
EPS
0.05%
4.86%
大文字化:
|
ボリューム (24 時間):